Get App Open
In App
Credit Cards
Open App

ITI Pharma & Healthcare Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 16.1935 0.1%
    (as on 19th November, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 98.31% investment in domestic equities of which 31.71% is in Large Cap stocks, 21.12% is in Mid Cap stocks, 15.23% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    NIFTY Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 19th November, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 12-Nov-25 9928.20 -0.72% - 0.08% 214/240
1 Month 17-Oct-25 9813.50 -1.86% - 0.75% 230/239
3 Month 19-Aug-25 9884.00 -1.16% - 2.82% 222/235
6 Month 19-May-25 10066.30 0.66% - 5.74% 211/225
YTD 01-Jan-25 9236.00 -7.64% - 4.47% 204/212
1 Year 19-Nov-24 9839.60 -1.60% -1.60% 7.15% 179/198
2 Year 17-Nov-23 14181.10 41.81% 19.00% 18.01% 63/154
3 Year 18-Nov-22 17001.20 70.01% 19.31% 18.96% 55/128
Since Inception 08-Nov-21 16193.50 61.94% 12.70% 12.67% 124/218

SIP Returns (NAV as on 19th November, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 19-Nov-24 12000 11986.63 -0.11 % -0.21 %
2 Year 17-Nov-23 24000 26082.17 8.68 % 8.2 %
3 Year 18-Nov-22 36000 45911.94 27.53 % 16.41 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Oct,2025)

Portfolio Turnover Ratio : 53.00%  |   Category average turnover ratio is 153.01%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 98.31% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 98.31%
No of Stocks : 40 (Category Avg - 44.44) | Large Cap Investments : 31.71%| Mid Cap Investments : 21.12% | Small Cap Investments : 15.23% | Other : 30.25%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 255.1 10.96% 0.34% 16.72% (Apr 2025) 10.6% (Aug 2025) 1.51 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 208.9 8.97% 1.18% 9.12% (May 2025) 4.77% (Nov 2024) 31.00 k 0.00
Apollo Hospitals Enterprises Ltd. Hospital 148 6.35% 0.54% 6.35% (Oct 2025) 4.75% (Nov 2024) 19.26 k 1.49 k
Max Healthcare Institute Ltd. Hospital 132.9 5.71% 0.01% 6.12% (Jun 2025) 3.53% (Nov 2024) 1.16 L 0.00
Torrent Pharmaceuticals Ltd. Pharmaceuticals 105.1 4.51% -0.08% 4.59% (Sep 2025) 3.53% (Dec 2024) 29.52 k 658.00
Suven Pharmaceuticals Ltd. Pharmaceuticals 103.3 4.43% -0.63% 6.06% (Feb 2025) 4.31% (Aug 2025) 1.37 L 6.78 k
Fortis Healthcare Ltd. Hospital 92.6 3.98% -0.15% 4.13% (Sep 2025) 1.36% (Nov 2024) 90.52 k -5.84 k
Aurobindo Pharma Ltd. Pharmaceuticals 86.1 3.70% 0.08% 4.94% (Dec 2024) 3.43% (Aug 2025) 75.61 k 0.00
Aster DM Healthcare Ltd. Hospital 84.4 3.62% 0.17% 3.62% (Oct 2025) 2.47% (Dec 2024) 1.24 L 0.00
Cipla Ltd. Pharmaceuticals 71.6 3.07% 0.86% 3.07% (Oct 2025) 1.01% (Jun 2025) 47.68 k 14.40 k
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
Net Receivables Net Receivables 1.69%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)

  • Standard Deviation

    Low volatility
    13.08vs13.95
    Category Avg
  • Beta

    Low volatility
    0.86vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    0.95vs0.91
    Category Avg
  • Treynor's Ratio

    Poor risk adjusted returns
    0.14vs0.17
    Category Avg
  • Jensen's Alpha

    Poor risk adjusted returns
    -0.09vs3.58
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 421.51 -1.10 10.41 43.44 40.35 33.75
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 273.51 -1.10 1.84 12.13 27.60 14.44
Quant BFSI Fund - Regular Plan - Growth NA 680.73 3.95 7.39 18.45 25.63 0.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1733.63 -0.08 4.88 18.40 22.68 0.00
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 9273.44 2.70 5.80 10.90 21.22 19.82
Franklin Asian Equity Fund - Growth NA 297.12 0.24 7.23 16.27 21.10 11.87
ITI Banking and Financial Services Fund - Regular Plan - Growth NA 333.18 3.65 7.41 8.67 21.00 13.66
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1518.73 1.44 5.90 7.09 20.99 0.00
Mirae Asset Banking and Financial Services Fund - Growth NA 2130.33 3.20 6.67 8.94 20.04 17.56
HDFC Banking and Financial Services Fund - Growth NA 4362.29 3.49 6.47 7.98 18.37 16.93

More Funds from ITI Asset Management Ltd.

Out of 19 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 1 is/are ranked 4 * , 3 is/are ranked 2 * , 1 is/are ranked 1 * , and 13 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
ITI Small Cap Fund - Regular Plan - Growth 5 2835.18 0.54 0.70 4.56 4.29 26.22
ITI Multi Cap Fund - Regular Plan - Growth 2 1325.85 1.66 2.67 5.26 5.74 19.27
ITI Mid Cap Fund - Regular Plan - Growth 2 1290.01 1.54 3.72 5.99 6.74 23.56
ITI Flexi Cap Fund - Regular Plan - Growth NA 1283.42 1.06 3.25 6.12 5.45 0.00
ITI Large & Mid Cap Fund - Regular Plan - Growth NA 901.34 0.73 2.61 2.87 4.30 0.00
ITI Focused Fund - Regular Plan - Growth NA 560.18 1.43 3.57 7.77 9.97 0.00
ITI Large Cap Fund - Regular Plan - Growth 1 535.61 0.94 3.00 3.21 6.42 13.34
ITI ELSS Tax Saver Fund - Growth 4 445.70 1.28 3.23 4.62 7.10 20.04
ITI Balanced Advantage Fund - Growth NA 400.05 0.76 2.55 4.36 6.16 11.57
ITI Value Fund - Growth 2 346.17 1.97 5.11 6.03 4.95 18.22
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347